Testing a new device feature to reduce signal noise in S-ICD patients
Part of Heart & circulation clinical trials.
This study tests whether a smart feature (Smart Pass) can reduce unwanted electrical signal interference in people with an implanted S-ICD. It may help the device work more smoothly and reduce potential noise-related problems.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old
- You have an implanted EMBLEM S-ICD (Models A 209 or A 219)
- You are not currently hemodynamically unstable (your blood circulation is stable)
- You can complete the required test/procedure (called TET) without major orthopedic limits
- You can understand and follow instructions well enough to complete the testing (no severe cognitive impairment)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether it is safe to play sports if you have a specific type of implanted defibrillator under the skin. It will track your device performance and exercise habits, using home monitoring, to understand any risks from sports.
This study looks at the beeping sound (alert tone) from a certain type of defibrillator placed under the skin. The goal is to understand if patients can hear and recognize these sounds, which could be important for safety.
This study tests a new alert system for people with pacemakers or defibrillators that can send information directly to your care team. The goal is to improve how quickly problems are found and treated.
This study tests a new type of defibrillator that goes underneath the skin, near your breastbone, to protect against dangerous heart rhythms. It may be an option if you need an ICD but haven't had certain prior chest surgeries or devices.
This study looks at implanting a type of ICD (implantable cardioverter-defibrillator) called a subcutaneous ICD, or S-ICD, which goes under the skin instead of in the heart. It is designed to help see how well this works in standard care.
This study checks how well implanted heart rhythm devices can detect rhythm problems in everyday patients. It may help improve detection and follow-up over the next year.
Hear when a new Subcutaneous ICD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.